Riskpilot← Back to searchSign inGet full accessBloom med. AB
ABActiveOrg 5592494990Durkgatan 3General medical practice activities · NACE 8621Est. 20201-4 employees
Revenue 2025
SEK 653K
-4% vs 2024
EBITDA margin
5.7%
-91% vs 2024
Equity ratio
87.3%
Financial strength
Net profit 2025
SEK 205K
-37% vs 2024
| Revenue | SEK 653K | -4% |
| EBITDA | SEK 37K | -91% |
| Net profit | SEK 205K | -37% |
| Total assets | SEK 1,9M | +2% |
| Equity | SEK 1,7M | +0% |
| Employees | — | — |
Legal name
Bloom med. AB
Org number
5592494990
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
24 mars 2020
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkarverksamhet inom primärvård.
Address
Durkgatan 3
Email
bloomseba@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 004 | 690 | 886 | 678 | 653 |
| Staff expenses | — | −5 | −0 | — | −327 |
| EBITDA | 801 | 541 | 627 | 418 | 37 |
| Depreciation & amort. | −0 | −10 | −10 | −10 | −10 |
| EBIT | 801 | 531 | 617 | 407 | 27 |
| Net financials | 83 | −2 | 73 | 1 | 184 |
| Profit before tax | 884 | 529 | 690 | 408 | 212 |
| Tax | −167 | −108 | −128 | −84 | −7 |
| Net profit | 717 | 421 | 562 | 324 | 205 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 229 | 1 352 | 1 820 | 1 912 | 1 943 |
| Equity | 981 | 1 214 | 1 581 | 1 701 | 1 696 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 248 | 138 | 239 | 211 | 247 |
| Total debt | 248 | 138 | 239 | 211 | 247 |
EBITDA margin
5.7%
This company
15.8%
Market median
-64% vs market
20212025
Equity ratio
87.3%
This company
38.2%
Market median
+129% vs market
20212025
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
20212025
Net profit margin
31.4%
This company
8.1%
Market median
+288% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bloom med. AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Percy Sebastian Bloom | Board of Directors | 0 companies |
| Carl-Göran Alexander Tilly | Deputy Board Member | 0 companies |
| Carl-Göran Alexander Tilly | Deputy Board Member | 0 companies |